Induction of morphological differentiation in the human leukemic cell line K562 by exposure to thalidomide metabolites.
about
Hydroxylated metabolites of thalidomide: formation in-vitro and in-vivo in man.Therapeutic renaissance of thalidomide in the treatment of haematological malignancies.Metabolism of thalidomide by human liver microsome cytochrome CYP2C19 is required for its antimyeloma and antiangiogenic activities in vitro.Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma.Effect of thalidomide in different tumors in rodents.
P2860
Induction of morphological differentiation in the human leukemic cell line K562 by exposure to thalidomide metabolites.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Induction of morphological dif ...... re to thalidomide metabolites.
@en
type
label
Induction of morphological dif ...... re to thalidomide metabolites.
@en
prefLabel
Induction of morphological dif ...... re to thalidomide metabolites.
@en
P2093
P1433
P1476
Induction of morphological dif ...... re to thalidomide metabolites.
@en
P2093
P304
P356
10.1016/0145-2126(91)90093-9
P577
1991-01-01T00:00:00Z